Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Open Source Software
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Edit functionality is currently unavailable.
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
The efficacy of the addition of nifedipine in patients with mixed angina compared to patients with classic exertional angina: a multicenter, randomized, double-blind, placebo-controlled clinical trial.
Medical therapy in acute coronary syndromes: which medicines and at what doses?
Nonantithrombotic medical options in acute coronary syndromes: old agents and new lines on the horizon.
ß-blockers and cardiovascular events in patients with and without myocardial infarction: post hoc analysis from the CHARISMA trial.
Calcium channel antagonists: friend or foe in postinfarction patients?
Effect of PCI on quality of life in patients with stable coronary disease.
Reducing post-myocardial infarction mortality in the elderly: the power and promise of secondary prevention.
Nifedipine-induced hypotension and myocardial ischemia in refractory angina pectoris.
Anti-ischaemic therapy during the follow-up phase of acute coronary syndromes. Is there a role for calcium channel blockers?
Strategies for managing the patient with acute non-Q-wave myocardial infarction.
Dofetilide for atrial fibrillation.
Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial.
Antianginal Therapy for Stable Ischemic Heart Disease: A Contemporary Review.
Beneficial effects of high-dose diltiazem in patients with persistent effort angina on beta-blockers and nitrates: a randomized, double-blind, placebo-controlled cross-over study.
Lack of diurnal variation in the onset of non-Q wave infarction.
Should Beta-Blockers Continue to Be Used in Post-Percutaneous Coronary Intervention Patients Without Myocardial Infarction?
Antianginal Agents for the Management of Stable Ischemic Heart Disease: A Review.
The post-myocardial infarction patient with hypertension. Long-term outcome.
Management of non-Q-wave myocardial infarction: role of diltiazem versus beta-blocker therapy.
Failure of adjuvant heparin to reduce myocardial ischemia in the early treatment of patients with unstable angina.
Optimal medical therapy with or without PCI for stable coronary disease.
Management of Coronary Disease in Patients with Advanced Kidney Disease.
Adrenergic beta Antagonists